Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Accounting (2)
- Administrative Law (2)
- Admiralty (2)
- Agency (2)
- Agriculture Law (2)
-
- Air and Space Law (2)
- Animal Law (2)
- Arts and Entertainment (2)
- Banking and Finance (2)
- Bankruptcy Law (2)
- Biography (2)
- Civil Law (2)
- Civil Rights and Discrimination (2)
- Commercial Law (2)
- Communications Law (2)
- Comparative and Foreign Law (2)
- Computer Law (2)
- Conflict of Laws (2)
- Constitutional Law (2)
- Consumer Protection Law (2)
- Contracts (2)
- Corporations (2)
- Courts (2)
- Criminal Law and Procedure (2)
- Dispute Resolution (2)
- Domestic Relations (2)
- Economics (2)
- Education Law (2)
- Elder Law (2)
- Publication
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Legal Profession
A Complete Property Right Amendment, John H. Ryskamp
A Complete Property Right Amendment, John H. Ryskamp
ExpressO
The trend of the eminent domain reform and "Kelo plus" initiatives is toward a comprehensive Constitutional property right incorporating the elements of level of review, nature of government action, and extent of compensation. This article contains a draft amendment which reflects these concerns.
Bond Repudiation, Tax Codes, The Appropriations Process And Restitution Post-Eminent Domain Reform, John H. Ryskamp
Bond Repudiation, Tax Codes, The Appropriations Process And Restitution Post-Eminent Domain Reform, John H. Ryskamp
ExpressO
This brief comment suggests where the anti-eminent domain movement might be heading next.
Do Reverse Payment Settlements Violate The Antitrust Laws, Christopher M. Holman
Do Reverse Payment Settlements Violate The Antitrust Laws, Christopher M. Holman
Faculty Works
The term "reverse payment" has been used as shorthand to characterize a variety of diverse agreements between patent owners and alleged infringers that involve a transfer of consideration from the patent owner to the alleged infringer. Reverse payment settlements are particularly associated with drug patent challenges mounted by generic drug companies under the Hatch-Waxman Act. Many, including the Federal Trade Commission, would characterize these agreements as antitrust violations. However, courts have generally declined to find these agreements in violation of the antitrust laws based solely on the presence of a reverse payment.
This article begins in Section II with an …